drug · antibody
patient view →obinutuzumab
Marketedupdated 2mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 20 investigational indications.
indications
investigational
Lupus
targets
B-lymphocyte antigen CD20
all catalysts(14)
approval · 14
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that